SINGAPORE, December 2, 2024 – George Clinical, a global leader in clinical research, has appointed Tony Proctor, C.P.A., as its new Chief Financial Officer (CFO). Tony brings over 25 years of financial leadership experience, known for his expertise in operational excellence, strategic planning, and transformational growth.
“I am honored to join George Clinical and contribute to its mission of improving health outcomes through innovative clinical research,” said Tony Proctor. “I look forward to partnering with the talented team to enhance financial operations and support the company’s global vision.”
Tony has held CFO and executive leadership roles at Lexitas, Parexel, and Syneos Health. He was a key architect of organic revenue acceleration initiatives at these organisations, implementing best-in-class financial disciplines, major organisational and systems upgrades, and transformative M&A processes. His leadership has consistently delivered measurable results, including driving strategic growth initiatives and optimising financial operations on a global scale.
“We are thrilled to welcome Tony to George Clinical at this exciting stage of our growth,” said Mary Gunn, CEO of George Clinical. “His extensive expertise in financial strategy and operational leadership will be instrumental in advancing our business and delivering exceptional value to customers across the globe.”
Tony Proctor holds an M.B.A. in Finance from Campbell University, a B.S. in Accounting, and a B.A. in Business/Finance from North Carolina State University. He is also a Certified Public Accountant (CPA) licensed in North Carolina.
About George Clinical
George Clinical is a globally recognized clinical research organisation (CRO) headquartered in Singapore. The company leverages scientific excellence and operational expertise to deliver comprehensive clinical trial services across all trial phases, supporting global clients in advancing health outcomes through innovative research.
Click Here to Join HR TODAY WhatsApp Channel
Read Also : People Analytics Teams Still Struggle to Deliver Business Impact, Warns The Josh Bersin Company
